Lymphomas
A Phase 2, Open-Label Trial to Evaluate Safety of Epcoritamab monotherapy in Subjects with Relapsed or Refractory Diffuse Large B-cell Lymphoma and Classic Follicular Lymphoma (Previously Grade 1-3a) when Administered in the Outpatient Setting (M23-362)
- Details
ClinicalTrials.gov ID:
NCT05451810
Diagnosis Type:
NA
USOR Number:
- Address
,
P: